This website uses cookies and similar technologies to provide the best functionality and display content according to your interests on our site and social networks.

We respect your privacy and process information only for marketing and functional purposes if you give us your consent by clicking ‘I accept.’
You can change your cookie settings at any time by clicking on the privacy settings.

Terms of use
Privacy Notice
Settings
This website uses cookies and similar technologies to provide the best functionality and display content according to your interests on our site and social networks.

We respect your privacy and process information only for marketing and functional purposes if you give us your consent by clicking ‘I accept.’
You can change your cookie settings at any time by clicking on the privacy settings.

Terms of use
Privacy Notice
This cookie is used for system purposes only and does not track user actions. It is required for normal functioning of this web site.
This is a web analytics service.
Processing company
  • Google Ireland Limited
  • Google Building Gordon House, 4 Barrow St, Dublin, D04 E5W5, Ireland
Data Purposes
  • Marketing
  • Advertisement
  • Web Analytics
Technologies Used
  • Cookies
  • Pixel Tags
Data Attributes
  • IP address (anonymised)
  • Browser information (browser type, referring/exit pages, the files viewed on our site, operating system, date/time stamp, and/or clickstream data)
  • Usage Data (views, clicks)
Data Collected
This list represents all (personal) data that is collected by or through the use of this service.
  • IP address
  • Date and time of visit
  • Usage data
  • Click path
  • App updates
  • Browser information
  • Device information
  • JavaScript support
  • Pages visited
  • Referrer URL
  • Downloads
  • Flash version
  • Location information
  • Purchase activity
  • Widget interactions
Legal Basis
  • In the following the legal basis for the processing of personal data required by Art. 6 I 1 GDPR is listed.
  • Art. 6 (1) (a) GDPR
Location of Processing
  • Republic of Serbia
Retention Period
  • The data will be deleted as soon as they are no longer needed for the processing purposes.
Data Recipients
  • Alphabet Inc.
This is a Tracking technology offered by Facebook and used by other Facebook services such as Facebook Custom Audiences.
Processing company
  • Facebook Ireland Limited
  • 4 Grand Canal Square, Grand Canal Harbour, Dublin, D02, Ireland
Data Purposes
  • advertising
  • Marketing
  • Retargeting
  • Analyse
  • Tracking
Technologies Used
  • Cookies
Data Attributes
  • Pixel specific data
  • Http-Header
  • Optional Parameters
Data Collected
This list represents all (personal) data that is collected by or through the use of this service.
  • Facebook user ID
  • Browser information
  • Usage data
  • Geräteinformationen
  • Non-sensitive custom data
  • Referrer URL
  • Pixel ID
  • Location information
  • Pixel specific data
  • User behaviour
  • Ads viewed
  • Interactions with advertisement, services, and products
  • Marketing information
  • Content viewed
  • IP address
Legal Basis
  • In the following the legal basis for the processing of personal data required by Art. 6 I 1 GDPR is listed.
  • Art. 6 para. 1 s. 1 lit. a GDPR
Location of Processing
  • Republic of Serbia
Retention Period
  • The data will be deleted as soon as they are no longer needed for the processing purposes.
Data Recipients
  • Facebook Inc.
Business
Hemofarm is a company focused on the production of quality, affordable and safe medicinal products
The business priorities of the company are reflected in its continuous supply to local and foreign markets and with its ongoing commitment to the education and development of its employees as the most significant resource vital to the company’s growth.
Hemofarm The Leader
Hemofarm is the leading pharmaceutical manufacturer in the region, and simultaneously the largest exporter of pharmaceuticals in Serbia, as well as one of the main pillars of production in STADA.
The portfolio is focused on the most important pharmacotherapeutic groups such as products for cardiovascular diseases, antibiotics and neuropsychiatric products, which corresponds also to the epidemiological structure of the therapeutic indications.
Hemofarm’s over-the-counter products (OTC) hold the leading position in the pharmaceutical market of Serbia, with a share of 16.2%.

Hemofarm’s business imperative is the continuous improvement of its portfolio by the latest-generation medicinal products, as well as the development of new segments, primarily the oncology segment.

Operation within the STADA Group opens additional possibilities for the sale of Hemofarm’s products in the highly demanding EU markets.

The Rx pharmaceutical market is conditioned by the pricing policy stipulated by the Ministry of Health and the Ministry of Trade. In that sense, the prices of medicinal products are also conditioned and officially approved values, which are determined by these two competent ministries.
Hemofarm was the largest exporter of medicinal products in 2021, too.

Hemofarm is among the top 10 exporters in Serbia.
Intensive investment has been directed towards:
  • modernising manufacturing plants
  • expanding manufacturing and storage capacities, as well as transfer of STADA products
  • modernising laboratories (R&D, microbiological control, etc.)
  • implementation and development of SAP system at the level of Hemofarm
  • continuous improvement of employees
    •